Skip to content

EBIT at other companies

Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$14.44M+70.5%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$22.58M+49.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
Stryker logo
StrykerSYK
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$59.4M+13.3%
Gross profit$43.4M+13.4%
Operating income-$8.3M+24.1%
Net income-$10.7M-0.3%
EPS (diluted)-$0.45+2.2%

Balance sheet

See full
Cash & equivalents$14.2M-59.8%
Total debt$5.4M+271%
Total equity$338.7M-2.4%
Total assets$502.2M+6.8%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$1.8M-58.4%
Free cash flow-$5.0M+39.8%

Valuation

See full
Market cap$503.94M+0.3%
Enterprise value$495.11M+5.7%
P/S2.1×-0.3×

Profitability

See full
Gross margin73.1%+0.3pp
Operating margin-15%-1.6pp
Net margin-16.3%-2.1pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.6%+0.2pp
Debt / equity0.0×
Current ratio5.2×-1.0×

Where this comes from

Calculated from OrthoPediatrics’s reported figures.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OrthoPediatrics's EBIT?
OrthoPediatrics (KIDS) reported EBIT of -$8.34M in Q1 2026.
How has OrthoPediatrics's EBIT changed year-over-year?
OrthoPediatrics's EBIT increased by 24.1% year-over-year, from -$10.98M to -$8.34M.
What is the long-term trend for OrthoPediatrics's EBIT?
Over 4 years (2021 to 2025), OrthoPediatrics's EBIT has grown at a 21.5% compound annual growth rate (CAGR), from -$18.02M to -$39.24M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.